| Stage | MAR | % of rev | RRR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.0B | 100.00% | $510M | 100.00% | MAR ×13.73 |
| Gross profit | $1.5B | 22.03% | $315M | 61.83% | RRR +39.8pp |
| Operating income | $1.3B | 18.19% | $136M | 26.65% | RRR +8.5pp |
| Pre-tax income | $1.1B | 15.13% | $90M | 17.65% | RRR +2.5pp |
| Net income | $794M | 11.33% | $77M | 15.01% | RRR +3.7pp |
| Stage | MAR | RRR | Gap · A − B |
|---|---|---|---|
| Revenue | $7.0B100.00% | $510M100.00% | MAR ×13.73 |
| Gross profit | 22.03%$1.5B | 61.83%$315M | RRR +39.8pp |
| Operating income | 18.19%$1.3B | 26.65%$136M | RRR +8.5pp |
| Pre-tax income | 15.13%$1.1B | 17.65%$90M | RRR +2.5pp |
| Net income | 11.33%$794M | 15.01%$77M | RRR +3.7pp |
No shared counterparties.